Marc Voigt

Marc Voigt

Company: Immutep

Job title: Chief Executive Officer


Opening Remarks: Reviewing the Past 12 Months of LAG-3 Therapeutic Development 9:00 am

Major LAG-3 related developments in the past 12 months by the most relevant players BMS validating LAG-3 at ASCO 2021 and other recent relevant developments What to expect in the coming 12 months?Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.